Dashboard
Manage Tickers

OPTNOptiNose, Inc.

Nasdaq optinose.com


$ 1.07 $ 0.00 (-0.47 %)    

Tuesday, 14-May-2024 12:36:37 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 443.59 $ -1.19 (-0.27 %)
DIA $ 394.22 $ -0.87 (-0.22 %)
SPY $ 520.75 $ -1.43 (-0.27 %)
TLT $ 90.58 $ -0.03 (-0.03 %)
GLD $ 217.58 $ -0.26 (-0.12 %)
$ 1.17
$ 1.07
$ 1.07 x 100
$ 1.30 x 200
$ 1.07 - $ 1.09
$ 0.80 - $ 2.10
660,177
na
131.74M
$ 0.75
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-07-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-07-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-08-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 03-03-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-05-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-06-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-13-2018 12-31-2017 10-K
27 11-27-2017 09-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

optinose-expects-xhance-net-revenues-for-fy24-to-be-between-85m-95m-sees-average-xhance-net-revenue-per-prescription-to-exceed-230-prior-view-220
Optinose Expects XHANCE Net Revenues For F...
05/14/2024 11:07:15

Operating Expenses The Company expects total GAAP operating expenses (selling, general & administrative expenses and resear...

optinose-q1-eps-012-misses-011-estimate-sales-1488m-beat-1294m-estimate
OptiNose Q1 EPS $(0.12) Misses $(0.11) Est...
05/14/2024 11:03:39

OptiNose (NASDAQ:OPTN) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.11) by...

optinose-expects-xhance-net-revenues-to-be-between-85m-95m-for-2024
Optinose Expects Xhance Net Revenues To Be...
05/09/2024 11:44:42

optinose-announces-55m-registered-direct-offering-post-offering-cash-balance-of-100m-expected-to-fund-operating-plan-through-2025
Optinose Announces $55M Registered Direct ...
05/09/2024 11:44:14

hc-wainwright--co-reiterates-buy-on-optinose-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Opti...
04/29/2024 10:19:17

HC Wainwright & Co. analyst Matthew Caufield reiterates OptiNose (NASDAQ:OPTN) with a Buy and maintains $5 price target.

why-caterpillar-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Caterpillar Shares Are Trading Lower B...
04/25/2024 17:57:17

Core News & Articles
Market-Moving News for April 25th
04/25/2024 12:31:16

ULBI: 26% | Ultralife shares are trading higher after the company reported better-than-expected Q1 financial results.CDTX: 41% ...

optinose-provides-corporate-updates-expects-to-produce-positive-income-from-operations-for-full-year-2025
Optinose Provides Corporate Updates; Expec...
04/25/2024 11:29:57

In addition, the Company announced preliminary XHANCE net product revenue of $14.9 million for the three months ended March 31,...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/22/2024 20:31:12

lake-street-maintains-buy-on-optinose-raises-price-target-to-4
Lake Street Maintains Buy on OptiNose, Rai...
03/18/2024 13:34:58

Lake Street analyst Thomas Flaten maintains OptiNose (NASDAQ:OPTN) with a Buy and raises the price target from $3 to $4.

hc-wainwright--co-reiterates-buy-on-optinose-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Opti...
03/18/2024 10:58:31

HC Wainwright & Co. analyst Matthew Caufield reiterates OptiNose (NASDAQ:OPTN) with a Buy and maintains $5 price target.

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
03/15/2024 21:33:52

optinose-shares-resume-trade
OptiNose Shares Resume Trade
03/15/2024 20:20:46

trading-halt-halt-status-updated-at-41500-pm-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 4:15:...
03/15/2024 20:15:05

optinose-announces-that-fda-approved-xhance-nasal-spray-for-the-treatment-of-chronic-rhinosinusitis-without-nasal-polyps-in-patients-18-years-of-age-and-older
Optinose Announces That FDA Approved XHANC...
03/15/2024 19:37:23

trading-halt-halted-at-32616-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 3:26:16 p.m. ET - ...
03/15/2024 19:26:20

hc-wainwright--co-initiates-coverage-on-optinose-with-buy-rating-announces-price-target-of-5
HC Wainwright & Co. Initiates Coverage On ...
03/11/2024 11:12:15

HC Wainwright & Co. analyst Matthew Caufield initiates coverage on OptiNose (NASDAQ:OPTN) with a Buy rating and announce...

optinose-reports-fourth-quarter-and-full-year-2023-xhance-net-revenue-of-199m-and-71m
Optinose Reports Fourth Quarter And Full Y...
03/07/2024 12:06:40

optinose-q4-gaap-eps-009-inline-sales-1986m-beat-1923m-estimate
OptiNose Q4 GAAP EPS $(0.09), Inline, Sale...
03/07/2024 12:05:32

OptiNose (NASDAQ:OPTN) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 47.06...

earnings-scheduled-for-march-7-2024
Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION